Promising gene therapy for Duchenne muscular dystrophy
Duchenne Muscular Dystrophy - Practical Neurology
Daiichi Sankyo announces Phase 1/2 clinical trial results - Action Duchenne
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug - ScienceDirect
REGENXBIO Announces FDA Clearance of IND for Clinical Trial of RGX-202, a Novel Gene Therapy Candidate for Duchenne Muscular Dystrophy · BioBuzz
Clinical Trial Clearance for Gene Therapy Drug - CureDuchenne
CureDuchenne Congratulates Pfizer on Dosing First Patient in Phase III Clinical Trial for Duchenne Muscular Dystrophy - CureDuchenne
Peak functional ability and age at loss of ambulation in Duchenne muscular dystrophy - Zambon - 2022 - Developmental Medicine & Child Neurology - Wiley Online Library
Encouraging pipeline for DMD patients - Clinical Trials Arena
Clinical Trials Spotlight - Duchenne Muscular Dystrophy | Office of Research
Genome editing for Duchenne muscular dystrophy: a glimpse of the future? | Gene Therapy
Duchenne Muscular Dystrophy Disease - Global Clinical Trials Review, H2, 2020
About Clinical Trials – Defeat Duchenne Canada
SJD Barcelona Children's Hospital in a trial on Duchenne muscular dystrophy
Global Duchenne Muscular Dystrophy Clinical Trial Pipeline Highlights - 2021
Participants Sought for Clinical Trial to Test Vamorolone in DMD - Muscular Dystrophy Association
Clinical trial of gene therapy for Duchenne muscular dystrophy underway at University of Florida Health | UF Health, University of Florida Health
Research and Clinical Trials
VISION-DMD – Designed to ensure a timely & cost-effective drug development for Duchenne muscular dystrophy
Duchenne Drug Development Pipeline - Parent Project Muscular Dystrophy
First BMD Patients Dosed in Phase 1 Trial of Oral Therapy EDG-5506
Sarepta issues clinical trials update - Action Duchenne
Unmet needs in Duchenne muscular dystrophy will be partially met by the pipeline, says GlobalData - GlobalData
Wave Life Sciences Announces Positive Results of Phase 1 Trial of WVE-210201 for Duchenne Muscular Dystrophy - Muscular Dystrophy Association
Measurements Used in Clinical Trials for Duchenne Muscular Dystrophy – an Overview | Sarepta Therapeutics
![Top 10 Duchenne Muscular Dystrophy Clinical Trials [2022 Studies] | Power](https://pwr-og-img.withpower.com/Apply%20to%20this%20Phase%202%20clinical%20trial%20treating%20Muscular%20Dystrophies,%20Muscular%20Dystrophy,%20Duchenne,%20Duchenne's%20Muscular%20Dystrophy%20(DMD):%0A%0ASRP-5051%20for%20Muscular%20Dystrophies.png?md=1 "Top 10 Duchenne Muscular Dystrophy Clinical Trials [2022 Studies] | Power")
Top 10 Duchenne Muscular Dystrophy Clinical Trials [2022 Studies] | Power
Ongoing clinical trials 1 and approval status of therapeutic approaches... | Download Table
